156 related articles for article (PubMed ID: 37454032)
1. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, SMU-DDCS, harboring an IDH1 mutation.
Emori M; Nakahashi N; Takasawa A; Murata K; Murahashi Y; Shimizu J; Tsukahara T; Sugita S; Takada K; Hasegawa T; Osanai M; Iba K
Hum Cell; 2023 Nov; 36(6):2195-2203. PubMed ID: 37454032
[TBL] [Abstract][Full Text] [Related]
2. Distinct IDH1/2-associated Methylation Profile and Enrichment of
Dermawan JKT; Nafa K; Mohanty A; Xu Y; Rijo I; Casanova J; Villafania L; Benhamida J; Kelly CM; Tap WD; Boland PJ; Fabbri N; Healey JH; Ladanyi M; Lu C; Hameed M
Cancer Res Commun; 2023 Mar; 3(3):431-443. PubMed ID: 36926116
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1.
Oyama R; Kito F; Takahashi M; Sakumoto M; Shiozawa K; Qiao Z; Noguchi R; Kubo T; Toki S; Nakatani F; Yoshida A; Kawai A; Kondo T
Hum Cell; 2019 Apr; 32(2):202-213. PubMed ID: 30737713
[TBL] [Abstract][Full Text] [Related]
4. Clonality analysis and
Yang T; Bai Y; Chen J; Sun K; Luo Y; Huang W; Zhang H
J Bone Oncol; 2020 Jun; 22():100293. PubMed ID: 32742915
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone.
Chen S; Fritchie K; Wei S; Ali N; Curless K; Shen T; Brini AT; Latif F; Sumathi V; Siegal GP; Cheng L
Hum Pathol; 2017 Jul; 65():239-246. PubMed ID: 28552826
[TBL] [Abstract][Full Text] [Related]
6. A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.
Tsukamoto S; Mavrogenis AF; Nitta Y; Righi A; Masunaga T; Honoki K; Fujii H; Kido A; Tanaka Y; Tanaka Y; Errani C
Curr Oncol; 2024 Jan; 31(1):566-578. PubMed ID: 38275833
[TBL] [Abstract][Full Text] [Related]
7. A Case Report and Brief Literature Review on Dedifferentiated Chondrosarcoma in Proximal Phalanx: A Rare Location.
Desai K; Liu S; Baskovich B; Makary R
Cureus; 2022 Sep; 14(9):e29105. PubMed ID: 36249651
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of miRNA expression in dedifferentiated and well-differentiated components of dedifferentiated chondrosarcoma.
Karras FS; Schreier J; Körber-Ferl K; Ullmann SR; Franke S; Roessner A; Jechorek D
Pathol Res Pract; 2023 Apr; 244():154414. PubMed ID: 36963273
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and treatment outcomes of dedifferentiated and grade 3 chondrosarcoma: A multi-institutional study.
Kozawa E; Nishida Y; Kawai A; Hayakawa K; Setsu N; Kawashima H; Iwata S; Tsuchiya H; Tsukushi S; Takenaka S; Imanishi J; Baba I; Nagano A; Morii T; Shirai T; Shimizu K; Kawano H
Cancer Sci; 2022 Jul; 113(7):2397-2408. PubMed ID: 35485870
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of isocitrate dehydrogenase 1/isocitrate dehydrogenase 2 gene mutation and the d-2-hydroxyglutarate oncometabolite level in dedifferentiated chondrosarcoma.
Mohammad N; Wong D; Lum A; Lin J; Ho J; Lee CH; Yip S
Histopathology; 2020 Apr; 76(5):722-730. PubMed ID: 31609487
[TBL] [Abstract][Full Text] [Related]
11. Genomic Profiling Identifies Association of
Zhu GG; Nafa K; Agaram N; Zehir A; Benayed R; Sadowska J; Borsu L; Kelly C; Tap WD; Fabbri N; Athanasian E; Boland PJ; Healey JH; Berger MF; Ladanyi M; Hameed M
Clin Cancer Res; 2020 Jan; 26(2):419-427. PubMed ID: 31615936
[TBL] [Abstract][Full Text] [Related]
12. Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2.
Li X; Dean DC; Ferreira A; Nelson SD; Hornicek FJ; Yu S; Duan Z
Cancer Control; 2021; 28():10732748211045274. PubMed ID: 34767468
[TBL] [Abstract][Full Text] [Related]
13. Dedifferentiated chondrosarcoma of the middle finger arising from a solitary enchondroma: A case report.
Yonezawa H; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Morinaga S; Asano Y; Saito S; Tome Y; Ikeda H; Nojima T; Tsuchiya H
World J Clin Cases; 2022 Apr; 10(10):3297-3305. PubMed ID: 35647122
[TBL] [Abstract][Full Text] [Related]
14. Squamous cell carcinoma arising in dedifferentiated chondrosarcoma proved by isocitrate dehydrogenase mutation analysis.
Zhang Y; Paz Mejia A; Temple HT; Trent J; Rosenberg AE
Hum Pathol; 2014 Jul; 45(7):1541-5. PubMed ID: 24792622
[TBL] [Abstract][Full Text] [Related]
15. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours.
Amary MF; Bacsi K; Maggiani F; Damato S; Halai D; Berisha F; Pollock R; O'Donnell P; Grigoriadis A; Diss T; Eskandarpour M; Presneau N; Hogendoorn PC; Futreal A; Tirabosco R; Flanagan AM
J Pathol; 2011 Jul; 224(3):334-43. PubMed ID: 21598255
[TBL] [Abstract][Full Text] [Related]
16. Targeted Next-Generation Sequencing Identifies Molecular and Genetic Events in Dedifferentiated Chondrosarcoma.
Lucas CG; Grenert JP; Horvai A
Arch Pathol Lab Med; 2021 Aug; 145(8):1009-1017. PubMed ID: 33147331
[TBL] [Abstract][Full Text] [Related]
17. TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma.
Xu X; Tang X; Guo W; Yang K; Ren T
Tumour Biol; 2016 Oct; 37(10):14129-14140. PubMed ID: 27522523
[TBL] [Abstract][Full Text] [Related]
18. Targeted next-generation sequencing of dedifferentiated chondrosarcoma in the skull base reveals combined TP53 and PTEN mutations with increased proliferation index, an implication for pathogenesis.
Gao L; Hong X; Guo X; Cao D; Gao X; DeLaney TF; Gong X; Chen R; Ni J; Yao Y; Wang R; Chen X; Tian P; Xing B
Oncotarget; 2016 Jul; 7(28):43557-43569. PubMed ID: 27248819
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas.
Schoedel K; Miller V; Osei-Hwedieh D; Watters R; Duensing A; John I; Chandran U; Chang A; Soman V; Weiss K
J Bone Oncol; 2021 Aug; 29():100370. PubMed ID: 34094840
[TBL] [Abstract][Full Text] [Related]
20. A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma.
Bui N; Dietz H; Farag S; Hirbe AC; Wagner MJ; Van Tine BA; Ganjoo K; Jones RL; Keedy VL; Davis EJ
Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
